Responses

Download PDFPDF

Inhaled corticosteroids and adrenal insufficiency
Free
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • A rapid response is a moderated but not peer reviewed online response to a published article in a BMJ journal; it will not receive a DOI and will not be indexed unless it is also republished as a Letter, Correspondence or as other content. Find out more about rapid responses.
  • We intend to post all responses which are approved by the Editor, within 14 days (BMJ Journals) or 24 hours (The BMJ), however timeframes cannot be guaranteed. Responses must comply with our requirements and should contribute substantially to the topic, but it is at our absolute discretion whether we publish a response, and we reserve the right to edit or remove responses before and after publication and also republish some or all in other BMJ publications, including third party local editions in other countries and languages
  • Our requirements are stated in our rapid response terms and conditions and must be read. These include ensuring that: i) you do not include any illustrative content including tables and graphs, ii) you do not include any information that includes specifics about any patients,iii) you do not include any original data, unless it has already been published in a peer reviewed journal and you have included a reference, iv) your response is lawful, not defamatory, original and accurate, v) you declare any competing interests, vi) you understand that your name and other personal details set out in our rapid response terms and conditions will be published with any responses we publish and vii) you understand that once a response is published, we may continue to publish your response and/or edit or remove it in the future.
  • By submitting this rapid response you are agreeing to our terms and conditions for rapid responses and understand that your personal data will be processed in accordance with those terms and our privacy notice.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    High dose fluticasone and adrenal suppression
    • Joanne M. Balfe, Paediatric Specialist Registrar
    • Other Contributors:
      • Mervyn RH Taylor, Deirdre McGonagle, Mary McDonald

    Dear Editor

    Following the editorial by Russell [1] recommending a short synacthen test for asthmatics receiving fluticasone in a daily dose of 1000 mcg or above, we undertook a computer search of our records of asthmatic patients.

    Asthmatics have approximately 4000 consultations per year with our team. We identified 190 children taking inhaled fluticasone either alone or in combination with salmeterol. Of...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    Moderately high doses stilll need to be considered for very young children

    Dear Editor

    In relation to the question of adrenal suppression when using higher doses of inhaled corticosteroid, I believe there is an aspect of dose selection which has not been mentioned by previous authors.

    There is limited data on the question of intra-pulmonary drug deposition in children under 3 years but the studies that have been publised seem to indicate that around 1-2% of the drug released int...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    Response to Pearce and Mabin

    Dear Editor

    I have been disappointed by the lack of response to the paper by Todd et al. [1] and to my accompanying editorial,[2] and I am indebted to Pearce and Mabin for opening what I hope will be an interesting discussion, although I must take issue with much of what they say. Their opening comment to the effect that clinical studies rather than a questionnaire-based survey should form the basis for advice...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    Inhaled corticosteroids and adrenal insufficiency
    • Linda Pearce, Respiratory Nurse Consultant
    • Other Contributors:
      • David Mabin

    Dear Editor

    The editorial by Russell [1] suggests that when high dose inhaled steroids are being considered the use of fluticasone diproprionate should be avoided, on the basis of this survey.[2] Clinical studies rather than a questionnaire based survey should form the basis for such advice. Such studies show no increased risk of hypothalamic pituitary axis (HPA) suppression with fluticasone propionate when comp...

    Show More
    Conflict of Interest:
    None declared.